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Evaluating Eczema 
in Italy
Atopic dermatitis (AD) 
in children significantly 
affects the quality of life 
(QoL) of the whole family, 
and scales to measure this 
impact have been created. 
Neri and colleagues 
validated the Childhood 
Atopic Dermatitis Impact 
Scale (CADIS) in an Italian 
population as a measure 
of QoL in comparison with 
other scales. Differences 
that were observed in the 
CADIS were likely due to 
cultural differences because 
this scale was developed 
with a US population. The 
authors recommend a 
slightly shorter version (33 
items) to adequately capture 
psychometric properties of 
childhood AD in Italy.  
See page 2534
Rac and Ras
Rac1 has been implicated as a 
critical downstream effector 
of NRas mutations in lung 
tumors; however, the function 
of this GTPase remains 
unknown in melanoma, which 
most frequently harbors 
NRasQ61K mutations. Li and 
colleagues demonstrated 
that Rac1 activity is indeed 
required for NRasQ61K-induced 
dermal melanocyte survival 
and increased invasiveness 
in mice. Genetic deletion or 
pharmacological inhibition 
of Rac1 in melanoma tumors 
that express NRasQ61K halted 
tumor growth and spread to 
lymph nodes, suggesting that 
Rac1 may be a useful target 
for melanoma therapy.  
See page 2610
Profiling Psoriasis
The psoriasis transcriptome has been expanded 
over the past few decades with the development 
of higher-density arrays, improved biochemi-
cal methods, and better statistical methods for 
whole-genome transcript analysis. Using pro-
tein profiling of more than 90 serum proteins in 
a cohort of 85 paired lesional and nonlesional 
samples obtained from patients with moderate 
to severe psoriasis who were not receiving pso-
riasis treatment, Suárez-Fariñas and colleagues 
expanded the psoriasis skin transcriptome to 4,175 transcripts. Although significant new 
information was generated, these results were highly concordant with data from previ-
ous studies. Importantly, many novel gene products were linked to functional pathways 
associated with metabolic diseases/diabetes and cardiovascular diseases, suggesting a link 
between altered gene expression and comorbidity risk. See page 2552
Fortune Telling for BCC
Because of the substantial population of patients 
with multiple basal cell carcinomas (BCCs) 
and the high risk of future BCCs in this popula-
tion, Dyer and colleagues prospectively exam-
ined the predictors of BCCs in 1,131 individuals 
with at least two prior keratinocyte carcinomas 
in the Veterans Affairs (VA) Topical Tretinoin 
Chemoprevention Trial. The number of BCCs in 
the past five years was the most important predic-
tor; age, sun sensitivity, occupational exposure 
before age 30, and history of eczema were also important risk factors for future BCCs. The 
cumulative five-year risk of a new BCC in this VA population was 55%. Because recent 
sunscreen use and sun exposure were not good predictors, chemopreventive strategies are 
crucial for these patients. See page 2544
View of the Spectrum
Pathogenic autoantibodies to desmogleins (Dsg) 
3 and 1 have been identified in patients with 
pemphigus foliaceus and fogo selvagem (FS), 
although some evidence of autoantibodies to 
other desmosomal cadherins or E-cadherin has 
been reported. Examination of the autoantibody 
profiles in FS patients, healthy US controls, and 
healthy controls from an endemic FS area in 
Brazil revealed that FS patients and controls exhibited autoantibodies to Dsg1 as well as 
to seven other keratinocyte cadherins in the endemic area, but US controls did not. Flores 
and colleagues also reported that these autoantibody responses were largely correlated 
between FS patients and endemic controls, suggesting possible exposure to a common 
environmental antigen(s) with cross-reactivity to Dsg1/3, eventually leading to clinical dis-
ease in FS patients. See page 2573
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